Systemic TLR2 tolerance enhances central nervous system remyelination

Area of Science:

• Neuroimmunology
• Demyelinating Diseases
• Innate Immunity

Background:

• Multiple sclerosis (MS) involves CNS inflammation and impaired myelin repair.
• Toll-like receptor 2 (TLR2) signaling contributes to MS inflammation and hinders myelin repair.
• Reducing TLR2 signaling in innate immune cells may improve myelin repair in MS.

Purpose of the Study:

• To investigate the effect of reducing TLR2 signaling via TLR2 tolerance induction on CNS myelin repair.
• To assess if TLR2 tolerance can enhance myelin recovery in a mouse model of demyelination.

Main Methods:

• Cuprizone was used to induce demyelination in wild-type (WT) and TLR2-deficient (TLR2-/-) mice.
• WT mice received TLR2 ligands to induce tolerance or vehicle control during the remyelination phase.
• Remyelination was assessed using electron microscopy and immunohistochemistry of microglia and oligodendrocytes.

Main Results:

• TLR2 tolerance induction significantly enhanced myelin repair in WT mice, restoring myelin thickness and unmyelinated axon frequency.
• Enhanced remyelination correlated with a shift in microglia from a pro-inflammatory (iNOS+) to a pro-repair (Arg1+) phenotype.
• TLR2-/- mice exhibited enhanced myelin repair, confirming the role of reduced TLR2 signaling.

Conclusions:

• Reducing TLR2 signaling through tolerance induction significantly promotes CNS myelin repair.
• TLR2 tolerance shifts microglia towards a pro-repair phenotype, aiding remyelination.
• TLR2 tolerance offers a potential dual therapeutic strategy for MS, addressing both inflammation and repair.